Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 523

1.

Impact of a nurse-led home and clinic-based secondary prevention programme to prevent progressive cardiac dysfunction in high-risk individuals: the Nurse-led Intervention for Less Chronic Heart Failure (NIL-CHF) randomized controlled study.

Stewart S, Chan YK, Wong C, Jennings G, Scuffham P, Esterman A, Carrington M; NIL-CHF Investigators.

Eur J Heart Fail. 2015 Apr 21. doi: 10.1002/ejhf.272. [Epub ahead of print]

PMID:
25899895
2.

Pemphigus is associated with KIR3DL2 expression levels and provides evidence that KIR3DL2 may bind HLA-A3 and A11 in vivo.

Augusto DG, O'Connor GM, Lobo-Alves SC, Bass S, Martin MP, Carrington M, McVicar DW, Petzl-Erler ML.

Eur J Immunol. 2015 Apr 13. doi: 10.1002/eji.201445324. [Epub ahead of print]

PMID:
25867094
3.

Two related trypanosomatid eIF4G homologues have functional differences compatible with distinct roles during translation initiation.

Moura DM, Reis CR, Xavier CC, da Costa Lima TD, Lima RP, Carrington M, de Melo Neto OP.

RNA Biol. 2015 Mar 4;12(3):305-19. doi: 10.1080/15476286.2015.1017233.

PMID:
25826663
4.

Prevalence and treatment of familial hypercholesterolaemia in Australian communities.

Watts GF, Shaw JE, Pang J, Magliano DJ, Jennings GL, Carrington MJ.

Int J Cardiol. 2015 Apr 15;185:69-71. doi: 10.1016/j.ijcard.2015.03.027. Epub 2015 Mar 3. No abstract available.

PMID:
25791093
5.

Composite outcome measures in a pragmatic clinical trial of chronic heart failure management: A comparative assessment.

Chang S, Davidson PM, Newton PJ, Macdonald P, Carrington MJ, Marwick TH, Horowitz JD, Krum H, Reid CM, Chan YK, Scuffham PA, Sibbritt D, Stewart S; WHICH Investigators.

Int J Cardiol. 2015 Apr 15;185:62-8. doi: 10.1016/j.ijcard.2015.03.071. Epub 2015 Mar 5.

PMID:
25791092
6.

Relative Expression Levels of the HLA Class-I Proteins in Normal and HIV-Infected Cells.

Apps R, Meng Z, Del Prete GQ, Lifson JD, Zhou M, Carrington M.

J Immunol. 2015 Apr 15;194(8):3594-600. doi: 10.4049/jimmunol.1403234. Epub 2015 Mar 9.

PMID:
25754738
7.

High throughput sequencing analysis of Trypanosoma brucei DRBD3/PTB1-bound mRNAs.

Das A, Bellofatto V, Rosenfeld J, Carrington M, Romero-Zaliz R, Del Val C, Estévez AM.

Mol Biochem Parasitol. 2015 Feb 25;199(1-2):1-4. doi: 10.1016/j.molbiopara.2015.02.003. [Epub ahead of print]

PMID:
25725478
8.

Estimating the current and future prevalence of atrial fibrillation in the Australian adult population.

Ball J, Thompson DR, Ski CF, Carrington MJ, Gerber T, Stewart S.

Med J Aust. 2015 Jan 19;202(1):32-5.

PMID:
25588442
9.

High-density mapping of the MHC identifies a shared role for HLA-DRB1*01:03 in inflammatory bowel diseases and heterozygous advantage in ulcerative colitis.

Goyette P, Boucher G, Mallon D, Ellinghaus E, Jostins L, Huang H, Ripke S, Gusareva ES, Annese V, Hauser SL, Oksenberg JR, Thomsen I, Leslie S; International Inflammatory Bowel Disease Genetics Consortium; Australia and New Zealand IBDGC; Belgium IBD Genetics Consortium; Italian Group for IBD Genetic Consortium; NIDDK Inflammatory Bowel Disease Genetics Consortium; United Kingdom IBDGC; Wellcome Trust Case Control Consortium; Quebec IBD Genetics Consortium, Daly MJ, Van Steen K, Duerr RH, Barrett JC, McGovern DP, Schumm LP, Traherne JA, Carrington MN, Kosmoliaptsis V, Karlsen TH, Franke A, Rioux JD.

Nat Genet. 2015 Feb;47(2):172-9. doi: 10.1038/ng.3176. Epub 2015 Jan 5.

PMID:
25559196
10.

Structural basis for ligand and innate immunity factor uptake by the trypanosome haptoglobin-haemoglobin receptor.

Lane-Serff H, MacGregor P, Lowe ED, Carrington M, Higgins MK.

Elife. 2014 Dec 12;3:e05553. doi: 10.7554/eLife.05553.

11.

Host genetic and viral determinants of HIV-1 RNA set point among HIV-1 seroconverters from sub-saharan Africa.

Mackelprang RD, Carrington M, Thomas KK, Hughes JP, Baeten JM, Wald A, Farquhar C, Fife K, Campbell MS, Kapiga S, Gao X, Mullins JI, Lingappa JR.

J Virol. 2015 Feb;89(4):2104-11. doi: 10.1128/JVI.01573-14. Epub 2014 Dec 3.

PMID:
25473042
12.

Standard versus atrial fibrillation-specific management strategy (SAFETY) to reduce recurrent admission and prolong survival: pragmatic, multicentre, randomised controlled trial.

Stewart S, Ball J, Horowitz JD, Marwick TH, Mahadevan G, Wong C, Abhayaratna WP, Chan YK, Esterman A, Thompson DR, Scuffham PA, Carrington MJ.

Lancet. 2015 Feb 28;385(9970):775-84. doi: 10.1016/S0140-6736(14)61992-9. Epub 2014 Nov 17.

PMID:
25467562
13.

Impaired platelet nitric oxide response in patients with new onset atrial fibrillation.

Procter NE, Ball J, Liu S, Hurst N, Nooney VB, Goh V, Stafford I, Heresztyn T, Carrington M, Ngo DT, Hylek EM, Isenberg JS, Chirkov YY, Stewart S, Horowitz JD; SAFETY Investigators.

Int J Cardiol. 2015 Jan 20;179:160-5. doi: 10.1016/j.ijcard.2014.10.137. Epub 2014 Oct 23.

PMID:
25464437
14.

Association between CTL Precursor Frequency to HLA-C Mismatches and HLA-C Antigen Cell Surface Expression.

Israeli M, Roelen DL, Carrington M, Petersdorf EW, Claas FH, Haasnoot GW, Oudshoorn M.

Front Immunol. 2014 Oct 27;5:547. doi: 10.3389/fimmu.2014.00547. eCollection 2014.

15.

HLA-C expression levels define permissible mismatches in hematopoietic cell transplantation.

Petersdorf EW, Gooley TA, Malkki M, Bacigalupo AP, Cesbron A, Du Toit E, Ehninger G, Egeland T, Fischer GF, Gervais T, Haagenson MD, Horowitz MM, Hsu K, Jindra P, Madrigal A, Oudshoorn M, Ringdén O, Schroeder ML, Spellman SR, Tiercy JM, Velardi A, Witt CS, O'Huigin C, Apps R, Carrington M; International Histocompatibility Working Group in Hematopoietic Cell Transplantation.

Blood. 2014 Dec 18;124(26):3996-4003. doi: 10.1182/blood-2014-09-599969. Epub 2014 Oct 16.

PMID:
25323824
16.

Systematic review of trial-based analyses reporting the economic impact of heart failure management programs compared with usual care.

Maru S, Byrnes J, Carrington MJ, Stewart S, Scuffham PA.

Eur J Cardiovasc Nurs. 2014 Oct 16. pii: 1474515114556031. [Epub ahead of print]

PMID:
25322749
17.

Relationship of HIV reservoir characteristics with immune status and viral rebound kinetics in an HIV therapeutic vaccine study.

Li JZ, Heisey A, Ahmed H, Wang H, Zheng L, Carrington M, Wrin T, Schooley RT, Lederman MM, Kuritzkes DR; ACTG A5197 Study Team.

AIDS. 2014 Nov 28;28(18):2649-57. doi: 10.1097/QAD.0000000000000478.

PMID:
25254301
18.

HIV-1 DNA predicts disease progression and post-treatment virological control.

Williams JP, Hurst J, Stöhr W, Robinson N, Brown H, Fisher M, Kinloch S, Cooper D, Schechter M, Tambussi G, Fidler S, Carrington M, Babiker A, Weber J, Koelsch KK, Kelleher AD, Phillips RE, Frater J; SPARTACTrial Investigators.

Elife. 2014 Sep 12;3:e03821. doi: 10.7554/eLife.03821.

19.

Depletion of the RNA-binding protein RBP33 results in increased expression of silenced RNA polymerase II transcripts in Trypanosoma brucei.

Fernández-Moya SM, Carrington M, Estévez AM.

PLoS One. 2014 Sep 12;9(9):e107608. doi: 10.1371/journal.pone.0107608. eCollection 2014.

20.

Early immune adaptation in HIV-1 revealed by population-level approaches.

Martin E, Carlson JM, Le AQ, Chopera DR, McGovern R, Rahman MA, Ng C, Jessen H, Kelleher AD, Markowitz M, Allen TM, Milloy MJ, Carrington M, Wainberg MA, Brumme ZL.

Retrovirology. 2014 Aug 29;11:64. doi: 10.1186/s12977-014-0064-1.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk